Pro# CYP-CL-002: A Clinical Validation Study of Cell Bound Complement Activation Products and Double Stranded DNA Auto-Antibodies in Subjects with Systemic Lupus Erythematosus versus Other Rheumatic Diseases and Healthy Normal Volunteers: Complement Activ

Project: Research project

Project Details

StatusFinished
Effective start/end date6/8/10 → 6/8/13

Funding

  • Cypress Bioscience, Inc. (CYP-CL-002)